$51.76+0.56 (+1.09%)
Truist Financial Corporation, a financial services company, provides banking and trust services in the Southeastern and Mid-Atlantic United States.
Truist Financial Corporation in the Financial Services sector is trading at $51.76 with a market capitalization of $61.1B. Wall Street consensus targets $54.86 (18 analysts), implying a +6.0% move over the next 12 months. The stock is currently 8% below its 52-week high of $56.20, remaining 8.1% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $5.15Bβ | $5.25Bβ | $5.19Bβ | $4.99Bβ | $4.90B |
| Gross Profit | β | β | β | β | β |
| Operating Income | β | β | β | β | β |
| Net Income | $1.48Bβ | $1.35Bβ | $1.45Bβ | $1.24Bβ | $1.26B |
Truist Financial Corporation, a financial services company, provides banking and trust services in the Southeastern and Mid-Atlantic United States. The company operates through two segments, Consumer and Small Business Banking; and Wholesale Banking....
The latest fair value estimate for Travelers Companies has moved from US$320.74 to US$354.71, an adjustment of about 11% that reframes how some analysts think about potential upside in the stock. This shift comes alongside a split in Street research, with more bullish voices pointing to strong Q2 execution and earnings power, while cautious analysts highlight valuation considerations and a softer insurance backdrop. As you read on, you will see how these differing views and evolving price...
The fair value estimate for Beta Bionics has moved from US$31.30 to US$19.80 per share, which places it closer to the current cluster of analyst price targets between US$13 and US$22. Recent commentary links this reset to a balance between optimism around iLet and the planned Mint launch, and caution related to medtech valuation resets and sector headwinds. As you read on, you will see how this shifting narrative and new assumptions might shape how you track Beta Bionics from here. Analyst...
PayPal stock inches higher as Truist upgrades the fintech firm to "Hold." Hereβs what made analyst Matthew Coad lift his rating on PYPL shares.
The latest analyst work on Ollie's Bargain Outlet Holdings centers on a reduced fair value estimate, moving from US$114.73 to US$109.13 and signaling a slightly more cautious stance on the stock. This reset lines up with research commentary that trims price targets while debating how much near term earnings and comp risk is already reflected, especially as opinions split over traffic trends, margins, and store growth plans. As you read on, you will see how these shifting targets fit into the...
Lenders had shunned the category just a few years ago, with investors and analysts warning of a wave of defaults.